Mazen M. Dimachkie

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.5Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America

BMJ Open(2020)10.1136/bmjopen-2020-037909

Top 23%

0.879DataRank

Top 23%20 citations

Richard J. Barohn, Emanuela Bartoccion, Michael Benatar, Derrick Blackmore, Vinay Chaudhry +35 more

Papers

Driven by 34 papers — median percentile 64. Top paper: “Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis”.

Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis

Neurology(2021)10.1212/wnl.0000000000013121

N/A

4.5DataRank · unranked

137 citations

Christopher S. Coffey, Jonathan M. Goldstein, Mazen M. Dimachkie, Michael Benatar, John T. Kissel +25 more

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

The Lancet Neurology(2021)10.1016/s1474-4422(21)00241-6

N/A

2.9DataRank · unranked

185 citations

Priya S. Kishnani, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar, Volker Straub +95 more

Predicting Outcome in Guillain-Barré Syndrome

Neurology(2021)10.1212/wnl.0000000000013139

N/A

2.5DataRank · unranked

68 citations

Hester F. Lingsma, Christa Walgaard, Badrul Islam, Nowshin Papri, Amy Davidson +95 more

Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis

Neurology(2022)10.1212/wnl.0000000000201501

N/A

1.2DataRank · unranked

25 citations

Andrzej Szczudlik, Antanas Vaitkus, Csilla Rózsa, Anna Kostera‐Pruszczyk, Petr Hon +20 more

Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease

Neurology(2022)10.1212/wnl.0000000000200746

N/A

1.2DataRank · unranked

48 citations

Richard J. Barohn, Barry J. Byrne, Özlem Göker-Alpan, Priya S. Kishnani, Shafeeq Ladha +19 more

Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America

BMJ Open(2020)10.1136/bmjopen-2020-037909

Top 23%

0.879DataRank

Top 23%20 citations

Richard J. Barohn, Emanuela Bartoccion, Michael Benatar, Derrick Blackmore, Vinay Chaudhry +35 more

Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial

The Lancet Neurology(2023)10.1016/s1474-4422(23)00275-2

N/A

0.867DataRank · unranked

34 citations

Michael McDermott, Thomas Blaettler, Claus Sundgreen, Anthony A. Amato, Emma Ciafaloni +74 more

The Impact of Diabetes and Metabolic Syndrome Burden on Pain, Neuropathy Severity and Fiber Type

Annals of Clinical and Translational Neurology(2025)10.1002/acn3.70072

Top 36%

0.537DataRank

Top 36%12 citations

Brian C. Callaghan, Lavanya Muthukumar, Simone Thomas, Evan L. Reynolds, A. Gordon Smith +9 more

Measurement Properties of 2 Novel PROs, the Pompe Disease Symptom Scale and Pompe Disease Impact Scale, in the COMET Study

Neurology Clinical Practice(2023)10.1212/cpj.0000000000200181

N/A

0.342DataRank · unranked

8 citations

Priya S. Kishnani, Cristina Ivanescu, Giulio Flore, Chad Gwaltney, Nadine A. M. E. van der Beek +8 more

Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study

Lara D. Veeken(2025)10.1093/rheumatology/keaf070

N/A

0.337DataRank · unranked

8 citations

Joachim Schessl, Zsuzsanna Bata‐Csörgõ, Mazen M. Dimachkie, Zoltán Griger, Sergey Moiseev +7 more

Item selection for the development and validation of a revised classification criteria for adult and juvenile idiopathic inflammatory myopathies: MyoROC project

Seminars in Arthritis and Rheumatism(2025)10.1016/j.semarthrit.2025.152822

Top 78%

0.104DataRank

Top 78%1 citations

Rachel Zeng, Stefanie Glaubitz, Matteo Bottai, Anthony A. Amato, Lorenzo Cavagna +19 more

Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials

Neurology(2023)10.1212/wnl.0000000000207278

N/A

0DataRank · unranked

27 citations

Michael Benatar, Volkan Granit, Ali A. Habib, James F. Howard, Carolina Barnett‐Tapia +7 more

Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review

Clinical and Experimental Rheumatology(2023)10.55563/clinexprheumatol/vuc5py

N/A

0DataRank · unranked

16 citations

Stefanie Glaubitz, Rachel Zeng, Matteo Bottai, Marianne de Visser, Mazen M. Dimachkie +14 more

Conducting a bayesian multi-armed trial with response adaptive randomization for comparative effectiveness of medications for CSPN

Contemporary Clinical Trials Communications(2023)10.1016/j.conctc.2023.101220

N/A

0DataRank · unranked

2 citations

Byron J. Gajewski, Dinesh Pal Mudaranthakam, Mamatha Pasnoor, Mazen M. Dimachkie, Omar Jawdat +4 more

Post-hoc Nonparametric Analysis of Forced Vital Capacity in the COMET Trial Demonstrates Superiority of Avalglucosidase Alfa vs Alglucosidase Alfa

Journal of Neuromuscular Diseases(2023)10.3233/jnd-230175

N/A

0DataRank · unranked

3 citations

Emmanuelle Salort Campana, Shahram Attarian, Jordi Díaz‐Manera, Mazen M. Dimachkie, Magali Periquet +5 more

Electrodiagnostic subtyping in Guillain–Barré syndrome patients in the International Guillain–Barré Outcome Study

European Journal of Neurology(2024)10.1111/ene.16335

N/A

0DataRank · unranked

11 citations

Judith Drenthen, Laura de Koning, Peter Van den Bergh, Robert D. M. Hadden, Satoshi Kuwabara +34 more

Resistance exercise in early-stage ALS patients, ALSFRS-R, Sickness Impact Profile ALS-19, and muscle transcriptome: a pilot study

Scientific Reports(2024)10.1038/s41598-024-72355-6

N/A

0DataRank · unranked

9 citations

Jason Rucker, Tomoki Nakano, Kotaro Takeno, Jeffrey Statland, Mamatha Pasnoor +12 more

Phenotypic spectrum of inclusion body myositis

Clinical and Experimental Rheumatology(2024)10.55563/clinexprheumatol/fhrx3q

N/A

0DataRank · unranked

7 citations

Mazen M. Dimachkie, Elie Naddaf, Bhaskar Roy

A protocol for scoping reviews on the role of whole-body and dedicated body-part magnetic resonance imaging for assessment of adult and juvenile idiopathic inflammatory myopathies

Rheumatology International(2024)10.1007/s00296-024-05649-7

N/A

0DataRank · unranked

6 citations

Daniel Brito de Araújo, Jessica Day, Edoardo Conticini, Mary Anne Riopel, Adriana Maluf Elias Sallum +31 more

Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS project

Lara D. Veeken(2025)10.1093/rheumatology/keaf229

N/A

0DataRank · unranked

7 citations

Tanya Chandra, Shiri Keret, John D Pauling, Ejaz A. Shamim, Francesco Bonella +31 more

Imaging evaluation of the upper limbs in inclusion body myositis: an unmet need

Clinical and Experimental Rheumatology(2025)10.55563/clinexprheumatol/q7ozm2

N/A

0DataRank · unranked

0 citations

Jasper M. Morrow, Sachit Shah, Michael G. Hanna, Mazen M. Dimachkie, Pedro Machado +1 more

A systematic review and meta-analysis of the response to placebo in clinical trials of inclusion body myositis

Lara D. Veeken(2025)10.1093/rheumatology/keaf146

N/A

0DataRank · unranked

0 citations

Michael Skolka, Larry J. Prokop, Mazen M. Dimachkie, Jean‐Yves Hogrel, Olivier Benveniste +5 more

Clinical features of LRP4/agrin‐antibody–positive myasthenia gravis: A multicenter study

Muscle & Nerve(2020)10.1002/mus.26985

N/A

0DataRank · unranked

89 citations

Brandy Quarles, Jin‐Xiu Pan, Yu Zheng, James F. Howard, Andrea M. Corse +22 more

Juvenile idiopathic inflammatory myopathies assessment by magnetic resonance imaging: a scoping review of protocols, scoring systems, and applications

Advances in Rheumatology(2025)10.1186/s42358-025-00494-z

N/A

0DataRank · unranked

0 citations

Clarissa Harumi Omori, Samuel Katsuyuki Shinjo, Daniel Brito de Araújo, Jessica Day, Adam Schiffenbauer +65 more

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Journal of Visualized Experiments(2020)10.3791/60638

N/A

0DataRank · unranked

7 citations

LaSharice Hall, April McVey, Richard J. Barohn, Jeffrey Statland, Omar Jawdat +3 more

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Journal of Visualized Experiments(2020)10.3791/60638-v

N/A

0DataRank · unranked

2 citations

LaSharice Hall, April McVey, Richard J. Barohn, Jeffrey Statland, Omar Jawdat +3 more

A Genome-Wide Association Study of Myasthenia Gravis

UNC Libraries(2020)10.17615/hk4s-3m41

N/A

0DataRank · unranked

0 citations

Emanuela Bartoccioni, Michael A. Nalls, Mamatha Pasnoor, Mario Sabatelli, April McVey +27 more

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis

Neurology(2021)10.1212/wnl.0000000000011626

N/A

0DataRank · unranked

37 citations

Michael G. Hanna, Pedro Machado, Umesh A. Badrising, Hector Chinoy, Olivier Benvéniste +93 more

Blood-based Biomarkers for Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis(2021)10.36255/exonpublications.amyotrophiclateralsclerosis.biomarkers.2021

N/A

0DataRank · unranked

8 citations

Mazen M. Dimachkie, Abdulbaki Aǵbaş, Heather Wilkins

The Early History of Arimoclomol for Inclusion Body Myositis

RRNMF Neuromuscular Journal(2021)10.17161/rrnmf.v2i2.15404

N/A

0DataRank · unranked

2 citations

Pedro Machado, Claus Sundgreen, Thomas Blaettler, Jeffery Statland, Andrew Heim +4 more

Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2108672119

N/A

0DataRank · unranked

133 citations

Sara Sáez-Atiénzar, Natalie A. Murphy, Adriano Chiò, Cornelis Blauwendraat, Ricardo H. Roda +48 more

The origins, evolution and future of the International Myositis Assessment and Clinical Studies Group (IMACS)

Clinical and Experimental Rheumatology(2022)10.55563/clinexprheumatol/yg743i

N/A

0DataRank · unranked

1 citations

Hector Chinoy, Mazen M. Dimachkie, Frederick W. Miller, Lisa G. Rider, David Isenberg

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative

Nature Reviews Rheumatology(2023)10.1038/s41584-023-01045-w

N/A

0DataRank · unranked

142 citations

Jeffrey P. Callen, Hector Chinoy, Leland W.K. Chung, David Fiorentino, Patrick Gordon +74 more

Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial

The Lancet Rheumatology(2023)10.1016/s2665-9913(23)00003-6

N/A

0DataRank · unranked

55 citations

Anthony A. Amato, Mazen M. Dimachkie, Hector Chinoy, Yessar Hussain, James B Lilleker +43 more

Mazen M. Dimachkie

Indexed papers

Top data-sharing exemplar

Papers